The aloxi 0.75mg is administered before the anti-cancer drug of day1 is administered.

2 trials

Sponsors

Kochi Health Sciences Center

Conditions

Gastric CancerGastric and Colorectal Cancer

Unknown Phase

A Clinical study to which Anti-emetic effect of change of 5-HT3RA is evaluated by using MAT in MEC for gastrointestinal cancer.

Active, not recruitingJPRN-UMIN000004133

Kochi Health Sciences CenterGastric and Colorectal Cancer

Start: 2010-10-01Target: 40Updated: 2026-06-29

A Clinical study to which Anti-emetic effect of 5-HT3RA is evaluated by using MAT in HEC for gastric cancer.

Active, not recruitingJPRN-UMIN000004135

Kochi Health Sciences CenterGastric Cancer

Start: 2010-11-01Target: 40Updated: 2026-06-29